SWOT Analysis for Bharat Parenterals Ltd.

Consistent Highest Return Stocks over Five Years
PEG lower than Industry PEG
Increasing Revenue every quarter for the past 2 quarters
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Stock with Low PE (PE < = 10)
Stocks Outperforming their Industry Price Change in the Quarter

Red Flag: High Interest Payments Compared to Earnings
Momentum Trap (DVM)
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Low DVM Stocks - Stocks to Exercise Caution On
Oversold by Money Flow Index (MFI)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Risky Value (DVM)
Low durability companies
Performance of Stocks with Low Trendlyne Durability Score versus Benchmarks
Inefficient use of capital to generate profits - RoCE declining in the last 2 years
Inefficient use of shareholder funds - ROE declining in the last 2 years
Inefficient use of assets to generate profits - ROA declining in the last 2 years
Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years
Low Piotroski Score : Companies with weak financials
Declining Net Cash Flow : Companies not able to generate net cash
Annual net profit declining for last 2 years
Major fall in TTM Net Profit
RSI indicating price weakness
Top Losers
Declining profitability: Falling ROCE